Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DIPYRIDAMOLE USP, with a corresponding US DMF Number 24441.
Remarkably, this DMF maintains an Active status since its submission on December 13, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 22, 2013, and payment made on July 23, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II